Tumor-associated endothelial cells display GSTPI and RARβ2 promoter methylation in human prostate cancer

Journal of Translational Medicine

Volumn 4, Issue , 2006, Pages

  Grover, Amelia C ^a   Tangrea, Michael A ^b   Woodson, Karen G ^a   Wallis, Benjamin S ^b   Hanson, Jeffrey C ^a   Chuaqui, Rodrigo F ^b   Gillespie, John W ^b   Erickson, Heidi S ^b   Bonner, Robert F ^c   Pohida, Thomas J ^d   Emmert Buck, Michael R ^b   Libutti, Steven K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Medical Oncology Branch   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE P1; RETINOIC ACID RECEPTOR BETA;

ARTICLE; CELL ISOLATION; DATA ANALYSIS; DNA DETERMINATION; ENDOTHELIUM CELL; EPIGENETICS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MICRODISSECTION; PHENOTYPE; POLYMERASE CHAIN REACTION; PROMOTER REGION; PROSTATE CANCER; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; PROTEIN METHYLATION; QUANTITATIVE ANALYSIS; TISSUE SECTION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM;

EID: 33645371806     PISSN: 14795876     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-4-13     Document Type: Article

References (12)

1. Shen L, Kondo Y, Rosner GL, Xiao L, Hernandez NS, Vilaythong J, Houlihan PS, Krouse RS, Prasad AR, Einspahr JG, Buckmeier J, Alberts DS, Hamilton SR, Issa JP: MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005, 97:1330-1338.
2. Hu M, Yao J, Cai L, Bachman KE, van den Brule F, Velculescu V, Polyak K: Distinct epigenetic changes in the stromal cells of breast cancers. Nat Genet 2005, 37:899-905.
3. Hanson JA, Gillespie JW, Grover A, Tangrea MA, Chuaqui RF, Emmert-Buck MR, Tangrea JA, Libutti SK, Linehan WM, Woodson KG: Identification of Gene Promoter Methylation in Tumor-Associated Stromal Cells. J Natl Cancer Inst 2006, 98:255-61.
4. St Croix B, Rago C, Velculescu V, Traverso G, Romans KE, Montgomery E, Lal A, Riggins GJ, Lengauer C, Vogelstein B, Kinzler KW: Genes expressed in human tumor endothelium. Science 2000, 289:1197-1202.
5. Tangrea MA, Chuaqui RF, Gillespie JW, Ahram M, Gannot G, Wallis BS, Best CJ, Linehan WM, Liotta LA, Pohida TJ, Bonner RF, Emmert-Buck MR: Expression microdissection: operator-independent retrieval of cells for molecular profiling. Diagn Mol Pathol 2004, 13:207-212.
6. Woodson K, Gillespie J, Hanson J, Emmert-Buck M, Phillips JM, Linehan WM, Tangrea JA: Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens. Prostate 2004, 60:25-31.
7. Woodson K, Hayes R, Wideroff L, Villaruz L, Tangrea J: Hypermethylation of GSTP1, CD44, and E-cadherin genes in prostate cancer among US Blacks and Whites. Prostate 2003, 55:199-205.
8. Woodson K, Hanson J, Tangrea J: A survey of gene-specific methylation in human prostate cancer among black and white men. Cancer Lett 2004, 205:181-188.
9. Gillespie JW, Best CJ, Bichsel VE, Cole KA, Greenhut SF, Hewitt SM, Ahram M, Gathright YB, Merino MJ, Strausberg RL, Epstein JI, Hamilton SR, Gannot G, Baibakova GV, Calvert VS, Flaig MJ, Chuaqui RF, Herring JC, Pfeifer J, Petricoin EF, Linehan WM, Duray PH, Bova GS, Emmert-Buck MR: Evaluation of non-formalin tissue fixation for molecular profiling studies. Am J Pathol 2002, 160:449-457.
10. Li LC, Carroll PR, Dahiya R: Epigenetic changes in prostate cancer: implication for diagnosis and treatment. J Natl Cancer Inst 2005, 97:103-115.
11. Singal R, Ferdinand L, Reis IM, Schlesselman JJ: Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. Oncol Rep 2004, 12:631-637.
12. Rak JW, St Croix BD, Kerbel RS: Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 1995, 6:3-18.